EOJOAM
REGN icon

E. Ohman J:or Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

E. Ohman J:or Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
3,840
+1,000
+35% +$681K 0.06% 176
2026
Q1 		$2.19M Hold
2,840
– – 0.06% 168
2025
Q4 		$2.19M Sell
2,840
-1,480
-34% -$1.01M 0.05% 174
2025
Q3 		$2.43M Hold
4,320
– – 0.06% 158
2025
Q2 		$2.27M Sell
4,320
-380
-8% -$212K 0.06% 158
2025
Q1 		$2.98M Sell
4,700
-270
-5% -$186K 0.08% 123
2024
Q4 		$3.54M Buy
4,970
+540
+12% +$453K 0.08% 114
2024
Q3 		$4.66M Sell
4,430
-280
-6% -$312K 0.12% 87
2024
Q2 		$4.95M Buy
4,710
+200
+4% +$194K 0.12% 93
2024
Q1 		$4.34M Buy
4,510
+310
+7% +$295K 0.11% 98
2023
Q4 		$3.69M Buy
+4,200
New +$3.46M 0.14% 90
2023
Q3 		– Sell
-9,329
Closed -$6.7M – 432
2023
Q2 		$6.7M Buy
9,329
+700
+8% +$540K 0.24% 61
2023
Q1 		$7.09M Buy
8,629
+900
+12% +$679K 0.28% 60
2022
Q4 		$5.58M Sell
7,729
-4,950
-39% -$3.65M 0.24% 68
2022
Q3 		$8.73M Sell
12,679
-4,204
-25% -$2.65M 0.4% 51
2022
Q2 		$9.98M Sell
16,883
-2,100
-11% -$1.37M 0.43% 47
2022
Q1 		$13.3M Buy
18,983
+13,883
+272% +$8.78M 0.44% 47
2021
Q4 		$3.22M Buy
5,100
+400
+9% +$246K 0.09% 137
2021
Q3 		$2.84M Buy
4,700
+200
+4% +$124K 0.09% 129
2021
Q2 		$2.51M Buy
4,500
+400
+10% +$203K 0.08% 154
2021
Q1 		$1.94M Sell
4,100
-100
-2% -$48.7K 0.07% 156
2020
Q4 		$2.03M Hold
4,200
– – 0.08% 132
2020
Q3 		$2.35M Buy
4,200
+400
+11% +$243K 0.12% 107
2020
Q2 		$2.37M Buy
3,800
+800
+27% +$454K 0.14% 95
2020
Q1 		$1.46M Sell
3,000
-800
-21% -$330K 0.11% 106
2019
Q4 		$1.43M Buy
3,800
+300
+9% +$101K 0.08% 148
2019
Q3 		$971K Sell
3,500
-41,674
-92% -$12.3M 0.06% 168
2019
Q2 		$14.1M Sell
45,174
-4,590
-9% -$1.53M 0.93% 27
2019
Q1 		$20.4M Buy
49,764
+7,759
+18% +$3.2M 1.38% 21
2018
Q4 		$15.7M Buy
42,005
+17,287
+70% +$6.33M 1.14% 28
2018
Q3 		$9.99M Buy
24,718
+1,737
+8% +$661K 0.65% 40
2018
Q2 		$7.93M Buy
22,981
+20,781
+945% +$6.5M 0.56% 48
2018
Q1 		$758K Sell
2,200
-300
-12% -$104K 0.06% 189
2017
Q4 		$940K Buy
2,500
+400
+19% +$162K 0.08% 165
2017
Q3 		$939K Hold
2,100
– – 0.08% 163
2017
Q2 		$1.03M Hold
2,100
– – 0.1% 143
2017
Q1 		$814K Buy
2,100
+400
+24% +$148K 0.1% 172
2016
Q4 		$624K Hold
1,700
– – 0.09% 178
2016
Q3 		$683K Buy
1,700
+200
+13% +$80.2K 0.1% 153
2016
Q2 		$524K Hold
1,500
– – 0.09% 172
2016
Q1 		$541K Hold
1,500
– – 0.1% 153
2015
Q4 		$814K Buy
1,500
+200
+15% +$108K 0.14% 122
2015
Q3 		$605K Sell
1,300
-300
-19% -$161K 0.16% 122
2015
Q2 		$816K Hold
1,600
– – 0.19% 114
2015
Q1 		$722K Hold
1,600
– – 0.17% 127
2014
Q4 		$653K Hold
1,600
– – 0.16% 139
2014
Q3 		$577K Hold
1,600
– – 0.14% 148
2014
Q2 		$452K Sell
1,600
-400
-20% -$119K 0.11% 190
2014
Q1 		$601K Hold
2,000
– – 0.15% 151
2013
Q4 		$556K Hold
2,000
– – 0.13% 163
2013
Q3 		$626K Buy
2,000
+400
+25% +$105K 0.16% 134
2013
Q2 		$360K Buy
+1,600
New +$373K 0.1% 220

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

E. Ohman J:or Asset Management's REGN Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 35% in Q2 2026, buying an estimated $681K and bringing the position to 3,840 shares worth $2.39M. The position accounts for 0.06% of the portfolio, ranked #176.

E. Ohman J:or Asset Management first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.4M in Q1 2019. 789 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • E. Ohman J:or Asset Management held 3,840 shares of Regeneron Pharmaceuticals worth $2.39M as of Q2 2026.
  • E. Ohman J:or Asset Management bought 1,000 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $681K.
  • Regeneron Pharmaceuticals made up 0.06% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #176 holding.
  • E. Ohman J:or Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • E. Ohman J:or Asset Management's Regeneron Pharmaceuticals position peaked at $20.4M in Q1 2019.
  • 789 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.